共 50 条
- [32] Metabolism disposition of lansoprazole in relation to the CYP2C19 phenotype status ACTA PHARMACOLOGICA SINICA, 2006, 27 : 224 - 224
- [36] Effects of allicin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes European Journal of Clinical Pharmacology, 2009, 65 : 601 - 608
- [38] Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations PHARMACOGENETICS, 1997, 7 (02): : 103 - 113
- [40] A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 290 (02): : 635 - 640